Tom Bilyeu

And this is a tradeoff.

So unless you guys are like, no, I love it the most that we have a K-shaped economy.

I love that.

Let's go.

More globalism.

If that's your argument, I'm happy to have that discussion.

But the reality is, if you want to start bringing this stuff back, get a middle class here.

You've got to give up on some of the benefits of globalism and start bringing it back.

Now, one pharma CEO warned that taxes on cutting edge medicines are going to increase costs and could jeopardize billions in U.S.

investments.

The White House, however, said for its part, prices are going to go down.

And a third opinion coming from a senior official is that the move just isn't going to impact affordability at all.

Now, one of these three is wrong.

So, sorry, two of the three are actually wrong.

Only one of the three is going to be right.

So which of them, we're going to see how this plays out.

Now, more than a dozen major drug makers, including Pfizer, Eli Lilly, and Novo Nordisk, have already inked pricing deals to avoid the tariffs.

So, yay!

Expect a wave of announcements like that from the holdouts in the coming weeks.

Now, given how much of the world's pharmaceuticals come from China, you can't ignore this.